5 latest FDA approvals

Here are the five latest drugs or medical devices approved by the Food and Drug Administration since August 4.

Advertisement
  1. Mavyret is intended to treat adults with all types of chronic hepatitis C virus with mild or no cirrhosis who have not previously received treatment for the
    illness.
  1. Besponsa is used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
  1. Vyxeos is intended to treat adults with two types of high-risk acute myeloid leukemia.
  1. Lynaparza may now be used for the ongoing treatment of patients with recurrent ovarian cancer who have responded to platinum-based chemotherapy.
  1. Serrato Pedicle Screw is intended for use in non-cervical procedures with the Xia 3 Spinal System.

More articles on supply chain:

7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.